| 2022 | | A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres | 노태훈 |
| 2020 | | A Simple and Practical Scoring System for Radiosurgical Treatment in Patients with Brain Metastases | 김세혁, 노태훈, 박범희, 유남규 |
| 2015 | | Clinical experience of glioma surgery using "tailed bullet": overcoming the limitations of conventional neuro-navigation guided surgery. | 김세혁 |
| 2010 | | Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions. | 김상현, 조경기 |
| 2017 | | Effectiveness of navigation-guided cyst aspiration before resection of large cystic brain tumors: a proof of concept for more radical surgery | 노태훈 |
| 2019 | | Epigenetic downregulation of STAT6 increases HIF-1alpha expression via mTOR/S6K/S6, leading to enhanced hypoxic viability of glioma cells | 김세혁, 김현미, 박수정, 조은혜, 주일로 |
| 2020 | | Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma | 노태훈 |
| 2016 | | Gamma Knife radiosurgery for cystic brain metastases | 김세혁 |
| 2011 | | Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells. | 김세혁 |
| 2018 | | Identifying candidates for gamma knife radiosurgery among elderly patients with brain metastases | 김세혁, 노태훈, 유남규, 정동환 |
| 2022 | | Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study) | 김세혁 |
| 2022 | | Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study | 김세혁 |
| 2017 | | Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis | 노태훈 |
| 2021 | | Mobile Phone Use and Time Trend of Brain Cancer Incidence Rate in Korea | 안영환 |
| 2012 | | Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases | 김보영, 김세혁, 김영배, 김장희, 신승수, 이기범, 이현우, 정선용, 한재호 |
| 2020 | | Predicting survival using the 2016 World Health Organization classification for anaplastic glioma | 노태훈 |
| 2018 | | Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation | 김세혁 |
| 2015 | | Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance. | 김세혁, 우현구 |
| 2015 | | Romo1 is associated with ROS production and cellular growth in human gliomas. | 김세혁 |
| 2010 | | Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma. | 조경기 |
| 2020 | | Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas | 노태훈 |
| 2022 | | The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study | 강석윤, 김세혁, 노오규, 노태훈, 신승수, 안미선, 오영택, 이현우, 최용원, 최진혁 |
| 2010 | | The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase. | 김성수, 김세중, 서해영, 유승완, 이영돈, 장다영, 조경기 |
| 2020 | | Treatment Results for Recurrent Glioblastoma and Alteration of Programmed Death-Ligand 1 Expression After Recurrence | 노태훈 |
| 2020 | | Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial | 김세혁 |
| 2017 | | Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma | 김세혁, 우현구 |
